Cortez AJ

ORCID: 0000-0003-1284-2638 · 3 papers in corpus · active 2016-2020
2020
Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer.
Cells ·doi:10.3390/cells9010149

Previously, based on a DNA microarray experiment, we identified a 96-gene prognostic signature associated with the shorter survival of ovarian cancer patients. We hypothesized that some differentially expressed protein-coding genes from thi…

2019
Characteristics of in Vivo Model Systems for Ovarian Cancer Studies.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics9030120

An understanding of the molecular pathogenesis and heterogeneity of ovarian cancer holds promise for the development of early detection strategies and novel, efficient therapies. In this review, we discuss the advantages and limitations of …

2016
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival.
Journal of cancer research and clinical oncology ·doi:10.1007/s00432-016-2147-y

PurposeOvarian cancer is typically diagnosed at late stages, and thus, patients' prognosis is poor. Improvement in treatment outcomes depends, at least partly, on better understanding of ovarian cancer biology and finding new molecular mark…